Bonovas, S., Lytras, T., Nikolopoulos, G., Peyrin-Biroulet, L., & Danese, S. (2018). Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors’ reply. Alimentary Pharmacology & Therapeutics, 47(4), 540-541. https://doi.org/10.1111/apt.14486

Allocca, M., Gilardi, D., Fiorino, G., Furfaro, F., Peyrin-Biroulet, L., & Danese, S. (2018). Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/MEG.0000000000001074 (Original work published 2018)

Olivera, P., Sandborn, W., Panés, J., Baumann, C., D’Haens, G., Vermeire, S., … Peyrin-Biroulet, L. (2018). Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.14514 (Original work published 2018)

Gabbiadini, R., Zacharopoulou, E., Furfaro, F., , Zilli, A., Gilardi, D., … Allocca, M. Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? Current Drug Targets, 22(3), 347-355. https://doi.org/10.2174/1389450121666201119142919 (Original work published 2021)